Misti Ushio
Fondateur chez TARA Biosystems, Inc.
Profil
Misti Ushio is a Managing Partner at Digitalis Ventures.
Dr. Ushio is formerly the CEO of TARA Biosystems which was acquired by ValoHealth in 2022.
Dr. Ushio has served most recently as Chief Strategy Officer and Managing Director of Harris & Harris Group.
Earlier in her career, Dr. Ushio held management roles at Merck & Company, where she developed vaccines and biologics products, and Columbia University, where she managed the intellectual property of several scientific and engineering portfolios.
She was graduated from Johns Hopkins University (B.S., Chemical Engineering), Lehigh University (M.S., Chemical Engineering) and University College London (Ph.D., Biochemical Engineering).
She also has served as a Director on the boards of private and public life science companies.
In 2018, she was named to Fast Company’s Top 100 Most Creative people in Business.
?
Postes actifs de Misti Ushio
| Sociétés | Poste | Début |
|---|---|---|
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Directeur/Membre du Conseil | - |
TARA Biosystems, Inc.
 TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Fondateur | 22/10/2014 |
ProMuc, Inc.
 ProMuc, Inc. BiotechnologyHealth Technology ProMuc, Inc. develops synthetic mucins for lubrication and antimicrobial applications. The company was founded by Katharina Ribbeck and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
| FastForward | Directeur/Membre du Conseil | - |
Digitalis Ventures LLC
 Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures LLC (Digitalis Ventures) is a venture capital firm founded in 2016 by Geoffrey W. Smith. The firm is headquartered in New York. | Private Equity Investor | 01/01/2023 |
| Digitalis Commons | Private Equity Investor | 01/01/2023 |
Anciens postes connus de Misti Ushio
| Sociétés | Poste | Fin |
|---|---|---|
| OPGEN, INC. | Directeur/Membre du Conseil | 01/04/2020 |
| 180 DEGREE CAPITAL CORP. | Corporate Officer/Principal | 29/02/2016 |
180 Degree Capital
 180 Degree Capital Investment Trusts/Mutual FundsMiscellaneous 180 Degree Capital (180 Degree Capital ) is a venture capital firm founded in 1981 by Douglas W. Jamison. The firm is headquartered in Montclair, New Jersey. | Private Equity Investor | 01/02/2016 |
| ░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ ░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Misti Ushio
| The Johns Hopkins University | Undergraduate Degree |
| Lehigh University | Graduate Degree |
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| OPGEN, INC. | Commercial Services |
 | Miscellaneous |
| Entreprise privées | 12 |
|---|---|
180 Degree Capital Corp.
 180 Degree Capital Corp. Investment ManagersFinance 180 Degree Capital Corp., a business development company listed on Nasdaq, invests in both public and private companies located in the United States. The fund targets companies operating across a broad range of sectors and industries. It makes controlling and non-controlling investments in the form of equity, preferred stock, warrants and debt. It considers co-investments and takes seat on the board of directors. | Finance |
Synglyco, Inc.
 Synglyco, Inc. Pharmaceuticals: MajorHealth Technology Synglyco, Inc. develops novel vaccines using synthetic carbohydrates. The firm's cutting edge technology enables the rapid, milligram to kilogram production of synthetic carbohydrates for use in drug discovery and industrial applications. Its proprietary platform generates significant quantities of chemically pure, complex carbohydrates through automated and manual chemical synthesis. The company was founded by Peter H. Seeberger, Carmichael S. Roberts Jr. Obadiah J. Plante and Louis Schofield on June 18, 2001 and is headquartered in New York, NY. | Health Technology |
Senova Systems, Inc.
 Senova Systems, Inc. Industrial MachineryProducer Manufacturing Senova Systems, Inc. develops and sells technology for measuring pH meters. It provides platform for the life science, food and beverage, dairy, petrochemical, water, and environmental sectors. The firm offers a pHit sensor platform which utilizes a carbon substrate containing proprietary analyte sensing molecules or ASMs. The company was founded by Gil M. Labrucherie, Robert L. Bratzler, Egisto Boschetti, Lee Leonard and Bernard Lemaitre in 2007 and is headquartered in Sunnyvale, CA. | Producer Manufacturing |
Enumeral Biomedical Corp.
 Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Enumeral Biomedical Corp. develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Its proprietary micro engraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The company was founded in 2009 by J. Christopher Love, Emanuele Ostuni and Barry Buckland and is headquartered in New York, NY. | Commercial Services |
AgBiome INC
AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Health Technology |
ProMuc, Inc.
ProMuc, Inc. BiotechnologyHealth Technology ProMuc, Inc. develops synthetic mucins for lubrication and antimicrobial applications. The company was founded by Katharina Ribbeck and is headquartered in Cambridge, MA. | Health Technology |
TARA Biosystems, Inc.
TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Technology Services |
| FastForward | |
Lodo Therapeutics Corp.
 Lodo Therapeutics Corp. BiotechnologyHealth Technology Lodo Therapeutics Corp. engages in the development of novel therapeutics from its metagenomics-based small molecule discovery platform. Its Lodo platform leverages breakthroughs in next-generation sequencing (NGS), artificial intelligence (AI), and machine learning (ML), along with advances in synthetic biology and automation. The company was founded by Sean Brady and David L. Pompliano and is headquartered in New York, NY. | Health Technology |
Petra Pharma Corp.
 Petra Pharma Corp. Pharmaceuticals: MajorHealth Technology Petra Pharma Corp. operates as a drug development company that develops novel small molecules for the treatment of cancer and metabolic diseases. The company was founded by Lewis Clayton Cantley and Nathanael S. Gray in 2016 and is headquartered in New York, NY. | Health Technology |
Digitalis Ventures LLC
Digitalis Ventures LLC Investment ManagersFinance Digitalis Ventures LLC (Digitalis Ventures) is a venture capital firm founded in 2016 by Geoffrey W. Smith. The firm is headquartered in New York. | Finance |
| Digitalis Commons |